Pfizer Inc. FY 2025 Earnings Analysis
Revenue declined 1.6% year over year. Year-over-year earnings remained under pressure, showing that the recovery in profitability is still incomplete.
Revenue trend
Revenue trend remains stable.
Margin and earnings quality
Profitability was broadly stable.
What matters next
Investor focus is likely to remain on whether management can restore earnings momentum over coming quarters.
Revenue & YoY Growth
AnnualRevenue trend and year-over-year growth across recent reported annual periods.
Net Income & Net Margin
AnnualNet income and net margin trend over recent reported annual periods.
Revenue Analysis
Pfizer Inc. reported $62.6B in revenue for FY 2025, down 1.6% YoY. The year-over-year decline indicates ongoing pressure on topline performance.
Profitability Analysis
Net income came in at $7.8B, down 3.1% YoY. Net margin was 12.4%. Sequential margin deterioration suggests profitability remains under pressure.
Frequently Asked Questions
Quick factual answers for this report. Need the why behind them? Ask the report assistant.
What was Pfizer Inc.'s revenue in FY 2025?
Pfizer Inc. reported revenue of $62.6B in FY 2025.
What was Pfizer Inc.'s net income in FY 2025?
Pfizer Inc. reported net income of $7.8B in FY 2025.
How did Pfizer Inc.'s revenue change year over year?
Pfizer Inc.'s revenue decreased by 1.6% year over year in FY 2025.
What was Pfizer Inc.'s net margin in FY 2025?
Pfizer Inc.'s net margin was 12.4% in FY 2025.
Compare this fiscal year with the previous annual earnings report.
Explore company profile, industry, and historical context.
View more quarterly financial trend pages for this company.
Data Source & Methodology
Financial data is sourced from company filings and internal processed earnings data.
YoY and QoQ values are derived from reported quarterly figures when not directly available.
This page is for informational purposes only and does not constitute investment advice.
